Literature DB >> 6225691

In situ characterization by monoclonal antibodies of the mononuclear cell infiltrate in chronic active hepatitis.

G Colucci, M Colombo, E Del Ninno, F Paronetto.   

Abstract

To characterize the inflammatory infiltrate of chronic active hepatitis we have examined 26 liver biopsy specimens [16 hepatitis B surface antigen-negative and 10 hepatitis B surface antigen-positive] with monoclonal antibodies and antiimmunoglobulins that react against the following mononuclear cell populations: T cells, T4 cells, T8 cells, monocytes-macrophages, Ia-positive cells, surface Ig-bearing cells, natural killer/killer cells. A biotin-avidin-fluorescein technique was used and the number of positive cells was counted in a portal tract that was more severely involved. The T cells predominate in all the specimens. The T4:T8 cell ratio and the number of T and T4 cells in the hepatitis B surface antigen-negative patients are higher than in the hepatitis B surface antigen-positive patients. While natural killer/killer cells, surface Ig-bearing cells, and macrophages are always rare, Ia-positive cells are numerous and the double-staining technique demonstrates a fair number of cells displaying both T-cell and Ia markers. These findings, while not supporting a major role of killer cells in chronic active hepatitis, suggest a different alteration of T-cell subsets in hepatitis B surface antigen-positive and -negative chronic active hepatitis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6225691

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  22 in total

1.  Flow cytometric and functional analysis of mononuclear cells infiltrating the liver in experimental autoimmune hepatitis.

Authors:  H Kohda; C Sekiya; M Kanai; Y Yoshida; T Uede; K Kikuchi; M Namiki
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

2.  Immunohistological characterization of intraepithelial and lamina propria lymphocytes in control ileum and colon and in inflammatory bowel disease.

Authors:  I Hirata; G Berrebi; L L Austin; D F Keren; W O Dobbins
Journal:  Dig Dis Sci       Date:  1986-06       Impact factor: 3.199

3.  Immunoelectron microscopic observations on Leu-7 positive cells in virus-related chronic liver diseases.

Authors:  H Himeno; H Enzan; T Saibara; S Onishi; Y Yamamoto
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

Review 4.  Autoimmune hepatitis.

Authors:  G Mieli-Vergani; D Vergani
Journal:  Arch Dis Child       Date:  1996-01       Impact factor: 3.791

5.  Natural killer activity in patients with chronic hepatitis treated with OK432, interferon, adenine arabinoside and glycyrrhizin.

Authors:  T Wada; T Arima; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1987-06

6.  In situ identification of immune competent cells in gastrointestinal mucosa: an evaluation by immunoelectronmicroscopy.

Authors:  M Vecchi; E Berti; M Primignani; M Monti; D Agape; G Torgano; E Arosio; R de Franchis
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

7.  Functional characterization of peripheral blood lymphocytes in chronic HBsAg carriers.

Authors:  G J Alexander; M Mondelli; N V Naumov; K T Nouriaria; D Vergani; D Lowe; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1986-03       Impact factor: 4.330

Review 8.  Autoimmune hepatitis. Evolving concepts and treatment strategies.

Authors:  A J Czaja
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

9.  Cellular immune response in liver of patients with chronic hepatitis B. Electron microscopic observation of lymphocyte subsets by the immunoperoxidase method using monoclonal antibodies.

Authors:  G Yamada; T Nishihara; I Hyodo; K Manabe; S Fujiki; H Okushin; M Mizuno; S Kinoyama; T Kobayashi; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1984-12

Review 10.  Drug therapy in the management of type 1 autoimmune hepatitis.

Authors:  A J Czaja
Journal:  Drugs       Date:  1999-01       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.